中國新城鎮(01278.HK)出資4.5億人民幣與無錫國資委成立合夥企業
中國新城鎮(01278.HK)公布,旗下新成開元及上海嘉通,與無錫國資委成立合夥企業旗下無錫國晟及無錫通匯訂立有限合夥協議,將成立合夥企業,共同向合夥企業認繳的出資9.01億元人民幣(下同)。
當中新成開元及上海嘉通作為優先級有限合夥人,分別承諾出資2.5億及2億元。無錫國晟作為普通合夥人,承諾出資100萬元,無錫通匯作為劣後級有限合夥人,承諾出資4.5億元。
該合夥企業將優先投資於物聯網、集成電路、生物醫藥、軟件與信息技術服務、高端裝備、高端製造、高端紡織服裝、節能環保、新材料、新能源、汽車及零部件(包括新能源汽車)、人工智能和元宇宙、量子科技、第三代半導體、氫能及儲能、深海裝備、基礎建設等領域,期限為五年。(gc/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.